This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          
HOPE LOGO

Dermatology

Topical ruxolitinib effective in non-segmental vitiligo
Topical ruxolitinib effective in non-segmental vitiligo
Read more
RCT finds dupilumab effective for children under six with atopic eczema
RCT finds dupilumab effective for children under six with atopic eczema
Read more
Sun awareness measures failing to alter behaviour
Sun awareness measures failing to alter behaviour
Read more
FDA approves ruxolitinib cream for vitiligo
FDA approves ruxolitinib cream for vitiligo
Read more
Stopping methotrexate for 2 weeks after COVID-19 vaccination boosts immune response
Stopping methotrexate for 2 weeks after COVID-19 vaccination boosts immune response
Read more
Green tea extract decreases severity of radiation-induced dermatitis in breast cancer patients
Green tea extract decreases severity of radiation-induced dermatitis in breast cancer patients
Read more
Different emollient formulations appear to be equally effective in childhood eczema
Different emollient formulations appear to be equally effective in childhood eczema
Read more
Older adults with atopic eczema at greater risk of developing Alzheimer’s disease
Older adults with atopic eczema at greater risk of developing Alzheimer’s disease
Read more
Cochrane systematic review answers only some questions on topical steroids use in eczema
Cochrane systematic review answers only some questions on topical steroids use in eczema
Read more
Cardiac biomarkers offer no benefit to CV risk stratification in psoriasis disease
Cardiac biomarkers offer no benefit to CV risk stratification in psoriasis disease
Read more
Psoriasis patients self-report higher analgesic usage largely due to joint pain
Psoriasis patients self-report higher analgesic usage largely due to joint pain
Read more
Lirentelimab effective for refractory chronic urticaria
Lirentelimab effective for refractory chronic urticaria
Read more
Tapinarof cream effective for moderately severe plaque psoriasis
Tapinarof cream effective for moderately severe plaque psoriasis
Read more
Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema
Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema
Read more
Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema
Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema
Read more
Ruxolitinib cream significantly improves patient outcomes in atopic dermatitis
Ruxolitinib cream significantly improves patient outcomes in atopic dermatitis
Read more
Chronic urticaria patients at risk of obstructive sleep apnoea
Chronic urticaria patients at risk of obstructive sleep apnoea
Read more

Popular articles

EUSEM: Diagnostic ability of ChatGPT comparable to emergency department clinicians
Ensitrelvir shows benefits for Covid-19 and long Covid in two studies
Ceiling-mounted IR systems: facilitating same-day prostate artery embolisation





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×